腹腔镜和开腹肝切除治疗肝癌的疗效分析

Efficacy of laparoscopic hepatectomy for the treatment of hepatocellular carcinoma

  • 摘要: 目的 探讨腹腔镜和开腹肝切除术治疗肝癌的疗效。方法 回顾性分析2011年1月至 12月广西医科大学附属肿瘤医院收治的30例肝癌患者的临床资料。根据手术方案和1∶2配对研究方法将所有患者分为腹腔镜组(10例)和开腹组(20例)。计量资料采用协方差分析,组间比较采用独立样本 t检验。结果 腹腔镜组患者中,7例行非规则性肝切除术,3例行规则性肝左外叶切除术,无中转手助式腹腔镜或开腹手术。开腹组患者中,14例行非规则性肝切除术,6例行规则性肝切除术。腹腔镜组患者术中平均出血量为(247±235)ml,显著低于开腹组患者的(408±191)ml(t=2.199,P<0.05)。腹腔镜组患者术后平均禁食时间、术后平均腹腔引流时间和术后平均住院时间分别为(1.9±0.6)d、(3.2±1.2)d、 (8.9±2.3)d,显著少于开腹组患者的(3.0±1.6)d、(4.9±1.6)d和(11.5±2.3)d(t=2.149,2.917, 2.921,P<0.05)。腹腔镜组患者肝功能恢复快于开腹组,其中腹腔镜组患者术后第1、3、5天ALT分别为 (228±100)U/L、(143±51)U/L、(85±24)U/L,AST分别为(196±67)U/L、(90±35)U/L、(46±10)U/L; 而开腹组患者术后第1、3、5天ALT分别为(557±401)U/L、(414±397)U/L、(217±199)U/L,AST分别为 (506±317)U/L、(178±122)U/L、(71±33)U/L,两组同时相点比较,差异有统计学意义(t=3.675、3.001、 2.073,4.196、2.223、2.272,P<0.05)。30例患者随访3~15个月,腹腔镜组患者中,1例术后4个月出现 AFP升高,CT检查示肝内多发肿瘤,经介入治疗后,病情稳定;开腹组患者中,1例术后7个月CT检查示手术切缘以及邻近肝段存在肿瘤复发,经RFA治疗,无再复发。其余患者无复发或转移。结论 腹腔镜肝切除术是一种安全有效的微创治疗方法。

     

    Abstract:

    Objective To investigate the efficacy of laparoscopic hepatectomy for the treatment of hepatocellular carcinoma (HCC). Methods The clinical data of 30 HCC patients who were admitted to the Affiliated Cancer Hospital of Guangxi Medical University from January 2011 to December 2011 were retrospectively analyzed. All patients were divided into the laparoscopic hepatectomy (LH) group (10 patients) and open hepatectomy (OH) group (20 patients) according to the operation patterns and at the ratio of 1 2. The degree of cirrhosis, size and location of tumor of the 2 groups were analyzed using the covariance analysis. The student t test was used for analysing the difference of the 2 groups. Results In the LH group, 7 patients received laparoscopic non anatomical liver resection, 3 received anatomical resection of the left lateral lobe, no patient was converted to the hand assisted laparoscopic surgery or open surgery. In the OH group, 14 patients received non anatomical liver resection, and 6 received anatomical liver resection. The volume of blood loss of the LH group was (247±235)ml, which was significantly lower than (408±191)ml of the OH group ( t=2.199, P <0.05). The mean postoperative fasting time, postoperative abdominal drainage time and duration of hospital stay of the LH group were (1.9± 0.6)days, (3.2±1.2)days and (8.9±2.3)days, which were significantly shorter than (3.0±1.6)days, (4.9±1.6)days and (11.5±2.3)days of the OH group ( t=2.149, 2.917, 2.921, P <0.05). The levels of alanine aminotransferase (ALT) of the LH group at day 1, 3, 5 were (228±100)U/L, (143±51)U/L, (85± 24)U/L, and the levels of aspartate aminotransferase (AST) of the LH group at day 1, 3, 5 were (196±67)U/L, (90±35)U/L, (46±10)U/L. The levels of ALT of the OH group at day 1, 3, 5 were (557±401)U/L, (414±397)U/L, (217±199)U/L, and the levels of AST of the OH group at day 1, 3, 5 were (506±317)U/L, (178±122)U/L, (71±33)U/L. The time for hepatic function recovery of the LH group was significantly shorter than that of the OH group ( t =3.675, 3.001, 2.073; 4.196, 2.223, 2.272, P <0.05). All the 30 patients were followed up for 3 15 months. The level of alpha fetoprotein of 1 patient in the LH group was increased at postoperative month 4, and the Results of computed tomography showed multiple intrahepatic lesions. The patient was cured by intervention treatment. One patient of the OH group was diagnosed as with tumor recurrence at the resection margins and adjacent hepatic segments. The patient was cured by radiofrequency ablation, with no tumor recurrence. No tumor recurrence or metastasis was observed in the other patients. Conclusion Laparoscopic hepatectomy is a feasible, safe and minimally invasive approach for patients with HCC.

     

/

返回文章
返回